Biotech Drug Factory

By Kate Greene

Description Text

To make its therapeutic proteins, Genentech first genetically modifies either Chinese hamster ovary (CHO) cells or E. coli bacteria, depending on the complexity of the desired protein. For mass production of the proteins, millions of the genetically engineered, protein-producing E. coli or CHO cells are added to a nutrient-rich growth medium